1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. POLYPID LTD
Polypid Ltd
XNAS: PYPD
3.79 -0.19 (-4.77%)
66,692.3
XNAS Volume

XNAS 28 Jul, 2026 10:53 AM (EDT)

Watchlist

Portfolio

Alert



Insider Trading disclosures for Polypid Ltd

The latest disclosure was made by Itzhak Krinsky in Polypid Ltd where a trade of 9,132 Stock option (right to buy) done was reported to US exchanges on July 15, 2026.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Itzhak Krinsky Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jul 2026 9,132 9,132 - - Stock option (right to buy)
Brooke Story Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jul 2026 9,132 9,132 - - Stock option (right to buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures